Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders?
Author:
- 1 February 2015
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 20 (2) , 262-266
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Genetics of Thoracic Aortic AneurysmCirculation Research, 2013
- Lessons on the pathogenesis of aneurysm from heritable conditionsNature, 2011
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK AntagonismScience, 2011
- Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome MiceScience, 2011
- Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic statesNature Medicine, 2007
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2Nature Genetics, 2005
- Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndromeJournal of Clinical Investigation, 2004
- Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndromeNature Genetics, 2003
- Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin geneNature, 1991